WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1983001311) IMPROVEMENTS RELATING TO LIGHT DELIVERY FOR TUMOUR TREATMENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1983/001311    International Application No.:    PCT/AU1982/000167
Publication Date: 14.04.1983 International Filing Date: 08.10.1982
IPC:
A61B 17/00 (2006.01), A61B 18/20 (2006.01), A61N 5/06 (2006.01), G02B 27/00 (2006.01), A61N 5/067 (2006.01)
Applicants: QUENTRON OPTICS PTY. LTD. [AU/AU]; 75A Angus Street, Adelaide, S.A. 5000 (AU) (For All Designated States Except US).
CHAPMAN, John, Gerald [GB/AU]; (AU) (For US Only)
Inventors: CHAPMAN, John, Gerald; (AU)
Agent: COLLISON & CO.; 97 King William Street, Adelaide, S.A. 5000 (AU)
Priority Data:
PF 1110 08.10.1981 AU
Title (EN) IMPROVEMENTS RELATING TO LIGHT DELIVERY FOR TUMOUR TREATMENT
(FR) AMELIORATIONS RELATIVES A LA DISTRIBUTION DE LUMIERE POUR LE TRAITEMENT DE TUMEURS
Abstract: front page image
(EN)A method and apparatus for providing separate secondary beams (23) of light from a primary light beam (21) achieved by locating diversionary means such as prisms (22) partially across the main beam (21) so that the degree of insertion provides for control of the magnitude of the secondary beam (23) especially useful for activating in more uniform manner a sensitizing drug when in a tumour. The secondary beams (23) can be commonly focused through lens (24) onto light fibre ends (25) for transmission into the activating areas.
(FR)Procédé et dispositif permettant d'obtenir des rayons lumineux secondaires séparés (23) à partir d'un rayon lumineux primaire (21), en disposant des organes de déviation tels que des prismes (22) partiellement au travers du rayon principal (21) de sorte que le degré d'insertion permet de commander la valeur des rayons secondaires (23) utiles notamment pour l'activation d'une manière plus uniforme d'un médicament de sensibilisation lorsque celui-ci se trouve dans une tumeur. Les rayons secondaires (23) peuvent être focalisés généralement au travers de la lentille (24) dans les extrémités des fibres optiques (25) pour la transmission dans les zones d'activation.
Designated States: AU, JP, US.
European Patent Office (AT, BE, CH, DE, FR, GB, LU, NL, SE).
Publication Language: English (EN)
Filing Language: English (EN)